Researchers develop genetically attenuated parasite (GAP) that arrests late in the liver stage of human malaria In an unprecedented first, scientists at Seattle Children’s Research Institute have developed a...
Researchers at UConn’s Center of Excellence in Vaccine Research (CEVR) have made a breakthrough in vaccine development for a common and difficult to treat pneumonia-causing pathogen. Their research was recently...
Sinovac Biotech announced preliminary study results. showing its experimental Covid-19 vaccine generated immune responses in patients and was safe — early data that suggest it might protect people against infections...
Vaccines are notoriously difficult to transport to remote or dangerous places, as they spoil when not refrigerated. Formulations are safe between 2°C and 8°C, but at other temperatures the proteins start to unravel...
According to many observations, certain virus infections may play a part in the autoimmune attack that leads to type 1 diabetes. Researchers at Karolinska Institutet and at the universities of Jyväskylä and Tampere have...
In order to immunize the world population both an effective vaccine and an efficient production process are necessary Even though there still isn’t a vaccine against the coronavirus, it is already being discussed which...
Infectious disease scientists report early development of a potential universal vaccine for Ebola viruses that preclinical tests show might neutralize all four species of these deadly viruses infecting people in recent...
New research highlights how urban expansion is creating the conditions for infectious diseases to emerge and spread around the world by blurring the classical boundaries between city, suburb, and countryside. An...
A virus-like particle vaccine was shown to be safe and well-tolerated among a healthy adult population living in chikungunya endemic areas, the researchers report in a new study published in the Journal of the American...
Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development process COVID-19 is a novel coronavirus, and the big unique challenge is not only is it a novel pathogen in...